Prevention of Primary Vascular Graft Infection with Silver-Coated Polyester Graft in a Porcine Model

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 4, 2010, Pages 472-477

  Gao, H ^a   Sandermann, J ^a   Prag, J ^a   Lund, L ^a   Lindholt, J S ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

Aortic graft infection; Aortic surgery; Porcine model; Staphylococcus aureus

Indexed keywords

BIOMATERIAL; C REACTIVE PROTEIN; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL GRAFT; CONTROLLED STUDY; FEMALE; GRAFT INFECTION; IMPLANTATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; SWINE; TEMPERATURE;

ACETATES; ANIMALS; ANTI-INFECTIVE AGENTS; AORTA; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; BODY TEMPERATURE; C-REACTIVE PROTEIN; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; FEMALE; LEUKOCYTE COUNT; MATERIALS TESTING; POLYESTERS; PROSTHESIS-RELATED INFECTIONS; SILVER COMPOUNDS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SWINE; TIME FACTORS; TREATMENT FAILURE;

EID: 77950058875     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.11.023     Document Type: Article

References (24)

1. Mussa F.F., Hedayati N., Zhou W., El-Sayed H.F., Kougias P., Darouiche R.O., et al. Prevention and treatment of aortic graft infection. Expert Rev Anti Infect Ther 5 (2007) 305-315
2. O'Brien T., and Collin J. Prosthetic vascular graft infection. Br J Surg 79 (1992) 1262-1267
3. Edwards Jr. W.H., Martin III R.S., Jenkins J.M., Edwards Sr. W.H., and Mulherin Jr. J.L. Primary graft infections. J Vasc Surg 6 (1987) 235-239
4. Seeger J.M. Management of patients with prosthetic vascular graft infection. Am Surg 66 (2000) 166-177
5. Perera G.B., Fujitani R.M., and Kubaska S.M. Aortic graft infection: update on management and treatment options. Vasc Endovascular Surg 40 (2006) 1-10
6. Kalteis T., Beckmann J., Schroder H.J., Schaumburger J., Linde H.J., Lerch K., et al. Treatment of implant-associated infections with moxifloxacin: an animal study. Int J Antimicrob Agents 27 (2006) 444-448
7. Hernandez-Richter T., Schardey H.M., Lohlein F., Heiss M.M., Redondo-Muller M., Hammer C., et al. The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig. Eur J Vasc Endovasc Surg 20 (2000) 413-418
8. Schierholz J.M., Lucas L.J., Rump A., and Pulverer G. Efficacy of silver-coated medical devices. J Hosp Infect 40 (1998) 257-262
9. Darouiche R.O. Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 29 (1999) 1371-1377
10. McDonnell G., and Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12 (1999) 147-179
11. Hernandez-Richter T., Schardey H.M., Wittmann F., Mayr S., Schmitt-Sody M., Blasenbreu S., et al. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material. Eur J Vasc Endovasc Surg 26 (2003) 550-557
12. Hardman S., Cope A., Swann A., Bell P.R., Naylor A.R., and Hayes P.D. An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts. Ann Vasc Surg 18 (2004) 308-313
13. Ueberrueck T., Zippel R., Tautenhahn J., Gastinger I., Lippert H., and Wahlers T. Vascular graft infections: in vitro and in vivo investigations of a new vascular graft with long-term protection. J Biomed Mater Res B Appl Biomater 74 (2005) 601-607
14. Goeau-Brissonniere O.A., Fabre D., Leflon-Guibout V., Di Centa I., Nicolas-Chanoine M.H., and Coggia M. Comparison of the resistance to infection of rifampicin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 35 (2002) 1260-1263
15. Schmacht D., Armstrong P., Johnson B., Pierre K., Back M., Honeyman A., et al. Graft infectivity of rifampicin and silver-bonded polyester grafts to MRSA contamination. Vasc Endovascular Surg 39 (2005) 411-420
16. Williams R.L., and Williams D.F. Albumin adsorption on metal surfaces. Biomaterials 9 (1988) 206-212
17. Shah P.M., Modak S., Fox C.L., Babu S.C., Sampath L., Clauss R.H., et al. PTFE graft treated with silver norfloxacin (AgNF): drug retention and resistance to bacterial challenge. J Surg Res 42 (1987) 298-303
18. Benvenisty A.I., Tannenbaum G., Ahlborn T.N., Fox C.L., Modak S., Sampath L., et al. Control of prosthetic bacterial infection: evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft. J Surg Res 44 (1988) 1-7
19. Kinney E.V., Bandyk D.F., Seabrook G.A., Kelly H.M., and Towne J.B. Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 50 (1991) 430-435
20. Bandyk D.F., Novotney M.L., Johnson B.L., Back M.R., and Roth S.R. Use of rifampicin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 95 (2001) 44-49
21. Atahan E., Gul M., Ergun Y., and Eroglu E. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model. Eur J Vasc Endovasc Surg 34 (2007) 182-187
22. Lehnhardt F.J., Torsello G., Claeys L.G., Pfeiffer M., Wachol-Drewek Z., Grundmann R.T., et al. Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: an experimental study. Eur J Vasc Endovasc Surg 23 (2002) 127-133
23. Koshiko S., Sasajima T., Muraki S., Azuma N., Yamazaki K., Chiba K., et al. Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg 35 (2002) 779-785
24. Javerliat I., Goeau-Brissonniere O., Sivadon-Tardy V., Coggia M., and Gaillard J.L. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics. J Vasc Surg 46 (2007) 1026-1031